Improving management through genetic testing for Familial Hypercholesterolaemia (FH)


This e-learning course addresses a need for improved understanding of the diagnosis and management of Familial Hypercholesterolaemia (FH), particularly through the use of genetic testing.

Learning outcomes

On completion of this e-learning course you will have an understanding of:

  • Key aspects of genetic testing in Familial Hypercholesterolaemia (FH)
  • How and why to test
  • How to interpret results
  • How to treat patients with FH
  • How to use cascade screening to identify related individuals at risk

Target audience

Cardiologists and Lipidologists

Summary of content

Heterozygous Familial Hypercholesterolaemia affects approximately 1 in 200–500 births, and patients with this hereditary disease are at markedly higher risk of cardiovascular disease. Early diagnosis and screening are key for improving outcomes in FH patient and yet rates of diagnosis of FH remain low in most parts of the world. Learn more about FH, its diagnosis and management alongside four global experts in the field by taking this e-learning course.

Expert contributors

  • Prof. Alain Carrié, University Hospital Pitié Salpêtrière, Paris, France
  • Prof. Eric Bruckert, University Hospital Pitié Salpêtrière, Paris, France
  • Prof. Christie Ballantyne, Baylor College of Medicine, Houston, USA
  • Prof. Christine Eng, Baylor College of Medicine, Houston, USA

Duration of training

Duration of training: It is expected that you will need at least one hour to review the full content of this training before you will be able to take the final assessment in order to receive either 1 ECMEC® or 1 EBAC credit.